PATZ1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.61700000000931E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.14900000000174E-05 |
Normal-vs-Stage2 |
9.53590000000171E-05 |
Normal-vs-Stage3 |
9.76740000000476E-05 |
Normal-vs-Stage4 |
1.23719999800542E-08 |
Stage1-vs-Stage2 |
2.630000E-01 |
Stage1-vs-Stage3 |
1.869420E-01 |
Stage1-vs-Stage4 |
1.041050E-04 |
Stage2-vs-Stage3 |
9.500000E-01 |
Stage2-vs-Stage4 |
1.511760E-02 |
Stage3-vs-Stage4 |
1.746140E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.7349999999492E-06 |
Normal-vs-AfricanAmerican |
9.79770000000268E-05 |
Normal-vs-Asian |
1.516020E-03 |
Caucasian-vs-AfricanAmerican |
9.344400E-01 |
Caucasian-vs-Asian |
1.310640E-01 |
AfricanAmerican-vs-Asian |
1.487780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.56620000002494E-06 |
Normal-vs-Female |
8.28860000000597E-05 |
Male-vs-Female |
4.667800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.122600E-03 |
Normal-vs-Extreme_Weight |
1.55229999998507E-06 |
Normal-vs-Obese |
5.79059999999965E-05 |
Normal-vs-Extreme_Obese |
2.455900E-03 |
Normal_Weight-vs-Extreme_Weight |
7.978400E-01 |
Normal_Weight-vs-Obese |
7.868200E-01 |
Normal_Weight-vs-Extreme_Obese |
5.799200E-01 |
Extreme_Weight-vs-Obese |
4.207400E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.085000E-01 |
Obese-vs-Extreme_Obese |
4.183000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.152200E-04 |
Normal-vs-Age(41-60Yrs) |
1.003310E-04 |
Normal-vs-Age(61-80Yrs) |
1.5869299999971E-05 |
Normal-vs-Age(81-100Yrs) |
1.004090E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.013400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.829600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.436800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.330200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.260000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.880020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.837700E-04 |
Normal-VS-Type2 PRCC |
9.05740038525948E-10 |
Normal-VS-KIRP CIMP |
1.75110000000256E-06 |
Normal-VS-Unclassified PRCC |
4.4462999999606E-06 |
Type1 PRCC-VS-Type2 PRCC |
1.60371999999853E-05 |
Type1 PRCC-VS-KIRP CIMP |
2.394900E-04 |
Type1 PRCC-VS-Unclassified PRCC |
1.962460E-02 |
Type2 PRCC-VS-KIRP CIMP |
4.834100E-02 |
Type2 PRCC-VS-Unclassified PRCC |
3.097200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.253830E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.03620000252636E-08 |
Normal-vs-N1 |
1.374100E-04 |
Normal-vs-N2 |
4.841800E-03 |
N0-vs-N1 |
6.927000E-01 |
N0-vs-N2 |
3.564600E-01 |
N1-vs-N2 |
3.802800E-01 |
|
|